Acanthamoeba Keratitis clinical trials at UCSF

1 research study open to eligible people

Acanthamoeba keratitis is an infection of the cornea caused by a tiny amoeba. UCSF is testing eye drops and topical steroids in controlled studies. UCSF is recording outcomes to compare safety and healing across centers.

Showing trials for

  • Parasitic Ulcer Treatment Trial

    open to eligible people ages 8 years and up

    The Parasitic Ulcer Treatment Trial (PUTT) is a multi-center, parallel-group, randomized clinical trial. The purpose of this study is to determine whether including topical corticosteroids in a regimen for acanthamoeba keratitis (AK) will improve vision. Patients presenting to all enrollment centers with evidence of acanthamoeba keratitis will be eligible for the trial if there is evidence of ocular inflammation after 4 weeks of anti-amoebic therapy. Those who agree to participate will be randomized to one of two treatment groups: - Group 1: Topical corticosteroid - Group 2: Topical placebo

    San Francisco, California and other locations

Our lead scientists for Acanthamoeba Keratitis research studies include .

Last updated: